Pascual Cruz Montserrat, Chimenos Küstner Eduardo, García Vicente José António, Mezquiriz Ferrero Xavier, Borrell Thio Eulalia, López López José
Médico estomatólogo, ABS (Area Básica de Salud) Sant Roc Badalona, Facultad de Medicina UAB, Spain.
Med Oral Patol Oral Cir Bucal. 2008 Feb 1;13(2):E98-101.
Increased plasma levels of cholesterol are high risk factors of cardiovascular disease. Statins are drugs that inhibit cholesterol synthesis at both pancreatic and extrahepathic levels, being the treatment of choice for hypercholesterolemia.
To analyze the side effects of statins in the mouth cavity, and to analyze the symptoms after interruption of the treatment.
Observational study, preliminary.
Patients aged 50-70, diagnosed with hypercholesterolemia and undergoing treatment with statins, referred from their primary care physician to the dentist's office. Anamnesis over oral symptoms was performed in the first visit. Statin treatment was discontinued, followed by lab tests and control visits seven and fifteen days later. We monitored the improvement and/or remission of oral symptoms. Statin treatment was resumed, sending out a report of the patient evolution to the PCP. Symptoms were registered in sheet specially designed for the study.
patient refusal, use of drugs for dry mouth treatment, Sjögren's syndrome.
n=26 patients. Dry mouth patients: improvement in 17 out of 23 patients (88.5%). Itchiness: 6 out of 15 cases improved (57.7%). Bitterness: improvement in 13 out of 14 patients (53.8%). Cough: improvement in 11 out of 12 patients (46.1%).
A high percentage of oral symptoms are associated to treatment with statins. There is a marked improvement after temporary interruption of the treatment. Little is known regarding the side effects of oral treatment with statins. This preliminary study includes a relatively small number of patients. The design of experimental treatments will be required to establish a true correlation between statin treatment and oral symptoms.
血浆胆固醇水平升高是心血管疾病的高风险因素。他汀类药物是在胰腺和肝外水平抑制胆固醇合成的药物,是高胆固醇血症的首选治疗药物。
分析他汀类药物在口腔中的副作用,并分析治疗中断后的症状。
初步观察性研究。
年龄在50 - 70岁、诊断为高胆固醇血症且正在接受他汀类药物治疗的患者,由其初级保健医生转诊至牙医诊所。首次就诊时进行口腔症状问诊。停用他汀类药物治疗,随后在7天和15天后进行实验室检查和复诊。我们监测口腔症状的改善和/或缓解情况。恢复他汀类药物治疗,并向初级保健医生发送患者病情进展报告。症状记录在专门为该研究设计的表格中。
患者拒绝、使用口干治疗药物、干燥综合征。
n = 26例患者。口干患者:23例中有17例改善(88.5%)。瘙痒:15例中有6例改善(57.7%)。口苦:14例中有13例改善(53.8%)。咳嗽:12例中有11例改善(46.1%)。
高比例的口腔症状与他汀类药物治疗有关。治疗暂时中断后有明显改善。关于他汀类药物口腔治疗的副作用知之甚少。这项初步研究纳入的患者数量相对较少。需要设计实验性治疗来确定他汀类药物治疗与口腔症状之间的真正关联。